Access the On-Demand Webinar
Recent final and proposed rulings will create the most significant changes to the Medication Adherence measures since 2012 when the measures were first introduced into the Star Ratings program.
Preparing for these changes should not be a daunting task, however. By combining learnings from best-in-class programs, mPulse partner plans have realized industry-leading medication adherence outcomes such as 175% improvement in refill adherence, with the ability to scale human services by 7X.
In this webinar, Prime Therapeutics and Magellan Rx's Nicole Grevenitz, Director of Clinical Program Account Management, mPulse’s Reva Sheehan, Sr. Director of Customer Insights and Brian Heacox, Director of Products and Growth, breakdown key regulatory changes plan are facing and use data from proven digital medication adherence programs to demonstrate the impact on outcomes across population segments.
Learn More About:
- Key regulatory changes and how they’ll impact MA’s most vulnerable populations
- Program results from leading digital medication adherence programs explained by the people who deployed them
- Innovative digital strategies to identify and address barriers hard-to-reach members face
